Evan Kearns
Fortune : 4 M $ au 31/08/2026
Fortune : 4 M $ au 31/08/2026
Evan D.
Kearns is Secretary & Chief Legal Officer at Cogent Biosciences, Inc. since 2021.
Mr. Kearns is Vice President at Acacia Partners LLC starting in 2025.
Formerly, Mr. Kearns was Secretary, Vice President & General Counsel at Agenus, Inc. from 2018 to 2021.
Mr. Kearns worked as an Associate at Goodwin Procter LLP.
Mr. Kearns completed undergraduate studies at Colby College in 2004 and graduate studies at The University of Toledo College of Law in 2007.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COGENT BIOSCIENCES, INC. 0,06 % | 26/12/2025 | 109 398 ( 0,06 % ) | 4 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Conseiller Juridique Général | 03/05/2021 |
Acacia Partners LLC
Acacia Partners LLC Investment ManagersFinance Acacia Partners invests in family owned/operated businesses located in the United States with an enterprise value of USD 50 - 250 million and EBITDA of minimum USD 5 million. The firm targets companies operating across a broad range of sectors and industries. It provides equity and debt financing for growth capital requirements and also makes both minority and majority investments. | Private Equity Investor | 01/10/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| AGENUS INC. | Conseiller Juridique Général | 30/04/2021 |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Cogent Biosciences, Inc.
Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Colby College
Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Toledo College of Law
The University of Toledo College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Partners LLC
Acacia Partners LLC Investment ManagersFinance Acacia Partners invests in family owned/operated businesses located in the United States with an enterprise value of USD 50 - 250 million and EBITDA of minimum USD 5 million. The firm targets companies operating across a broad range of sectors and industries. It provides equity and debt financing for growth capital requirements and also makes both minority and majority investments. | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national